Your Cart

Ambolyt Paediatric Drops

Ambolyt Paediatric Drops, 6839, Ambroxol
Ambolyt Paediatric Drops
0 Pcs sold
1368 Interested


• Acute and chronic diseases of respiratory tracts associated with viscid mucus including acute and chronic bronchitis

• Productive cough

• Inflammatory diseases of Rhinopharyngeal tract (e.g. Laryngitis, Pharyngitis, Sinusitis and Rhinitis) associated with viscid mucus

• Asthmatic bronchitis, Bronchial asthma with difficult departure of mucus

• Bronchiectasis

• Chronic pneumonia.


Ambroxolis a metabolite of Bromhexine. It possesses mucokinetic (improvement inmucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency. Beside these, Ambroxol also exhibits anti-oxidant activity. Long-term use is possible because of the good tolerability of the preparation.

Dosage & Administration

Average daily dose (preferably after meal).
Ambolyt Paediatric Drops:
0-6 months 0.5 ml 2 times a day
6-12 months 1 ml 2 times a day
1-2 years 1.25 ml 2 times a day
Ambolyt Syrup:
2-5 years 2.5 ml (1/2 teaspoonful) 2-3 times a day
5-10 years 5 ml (1 teaspoonful) 2-3 times a day
10 years and adults 10 ml (2 teaspoonful) 3 times a day.

Side Effects

Gastrointestinalside-effects like epigastric pain, gastric fullness may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema may occur.


Ambroxolshould be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.


Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.

Use in Pregnancy & Lactation

Pregnancy:Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use during pregnancy, especiallyin the 1st trimester.

Lactation: Safety during lactation has not been established.

Drug Interaction

Ambroxolhas no interaction with cardioactive glycosides, corticosteroids, bronchodilators, diuretics and antibiotics (normally used in the treatment of bronchopulmonary affections). But Ambroxol should not be taken simultaneously with antitussives (e.g. Codeine) because mucus, which has been liquefied by Ambroxol, might not be expectorated.

Commercial Packaging

Ambolyt Syrup: Amber color bottle containing 100 ml syrup and a measuring cup.
Ambolyt Paediatric Drops: Amber color bottle containing 15 ml paediatric drops and a calibrated dropper

Write a review

Note: HTML is not translated!
Bad Good